NorthStar Asset Management (Pennsylvania)’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,302
Closed -$203K 144
2021
Q2
$203K Hold
1,302
0.05% 141
2021
Q1
$202K Buy
+1,302
New +$202K 0.06% 138
2017
Q2
Sell
-2,435
Closed -$289K 112
2017
Q1
$289K Hold
2,435
0.13% 99
2016
Q4
$244K Hold
2,435
0.11% 106
2016
Q3
$307K Hold
2,435
0.13% 96
2016
Q2
$285K Hold
2,435
0.12% 96
2016
Q1
$252K Hold
2,435
0.11% 101
2015
Q4
$243K Hold
2,435
0.1% 99
2015
Q3
$222K Hold
2,435
0.1% 96
2015
Q2
$258K Hold
2,435
0.11% 94
2015
Q1
$278K Hold
2,435
0.12% 91
2014
Q4
$268K Hold
2,435
0.12% 91
2014
Q3
$238K Hold
2,435
0.1% 94
2014
Q2
$246K Hold
2,435
0.1% 94
2014
Q1
$224K Hold
2,435
0.1% 92
2013
Q4
$220K Buy
+2,435
New +$211K 0.1% 86

Other funds holding ZBH

NorthStar Asset Management (Pennsylvania)'s ZBH Position: Q3 2021 in Review

NorthStar Asset Management (Pennsylvania) sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 1,302 shares — an estimated $203K sold.

NorthStar Asset Management (Pennsylvania) first reported a position in ZBH in Q4 2013 and held it in 16 quarters. The position peaked at $307K in Q3 2016. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • NorthStar Asset Management (Pennsylvania) reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • NorthStar Asset Management (Pennsylvania) sold 1,302 Zimmer Biomet shares in Q3 2021, an estimated $203K.
  • NorthStar Asset Management (Pennsylvania) first reported a position in Zimmer Biomet in Q4 2013 and held it in 16 quarters.
  • NorthStar Asset Management (Pennsylvania)'s Zimmer Biomet position peaked at $307K in Q3 2016.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on NorthStar Asset Management (Pennsylvania)'s 13F filing for Q3 2021, filed 29 Oct 2021.